Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer: Overcoming Challenges in Genetic Testing and Clinical Considerations When Using Talazoparib. - Brugioni E; Cathcart-Rake E; Metsker J; Gustafson E; Douglass L; Pluard TJ (Clinical breast cancer, 2023)